UChicago Medicine Ingalls Memorial

Summary

UChicago Medicine Ingalls Memorial is a medical facility located in Harvey, Illinois. This center is recognized for care of Colorectal Cancer, Colon Cancer, Rectal Cancer, Bladder Cancer, Multiple Myeloma and other specialties. UChicago Medicine Ingalls Memorial is involved with conducting 3 clinical trials across 32 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at UChicago Medicine Ingalls Memorial

Bladder Cancer

Esophageal Cancer

Squamous Cell Carcinoma

Cervical Cancer

Transitional Cell Carcinoma

Esophageal Adenocarcinoma

Stomach Cancer

Lung Cancer

Ovarian Cancer

Gastroesophageal Junction Adenocarcinoma

Disitamab Vedotin + Pembrolizumab

for Bladder Cancer

This trial is testing a new drug called disitamab vedotin, alone or with pembrolizumab, for patients with advanced or metastatic HER2 expressing bladder cancer. Disitamab vedotin is designed to target HER2 and has been approved for other types of cancer. The study aims to see if these drugs can effectively treat the cancer and what side effects they might cause.

Recruiting

1 award

Phase 2

4 criteria

SGN-B6A

for Cancer

This trial is testing a new drug called sigvotatug vedotin alone and with other treatments to see if it is safe and effective for people with solid tumors. It will also check for any side effects. The study includes different parts to determine the best dose and to see how well the drug works alone and in combination with other treatments.

Recruiting

1 award

Phase 1